280 related articles for article (PubMed ID: 29153365)
1. Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study.
Jochelson MS; Pinker K; Dershaw DD; Hughes M; Gibbons GF; Rahbar K; Robson ME; Mangino DA; Goldman D; Moskowitz CS; Morris EA; Sung JS
Eur J Radiol; 2017 Dec; 97():37-43. PubMed ID: 29153365
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of contrast-enhanced digital mammography and contrast enhanced tomosynthesis--Comparison to contrast-enhanced breast MRI.
Chou CP; Lewin JM; Chiang CL; Hung BH; Yang TL; Huang JS; Liao JB; Pan HB
Eur J Radiol; 2015 Dec; 84(12):2501-8. PubMed ID: 26456307
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Enhanced Digital Mammography in the Surgical Management of Breast Cancer.
Ali-Mucheru M; Pockaj B; Patel B; Pizzitola V; Wasif N; Stucky CC; Gray R
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):649-655. PubMed ID: 27638679
[TBL] [Abstract][Full Text] [Related]
4. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Berg WA; Zhang Z; Lehrer D; Jong RA; Pisano ED; Barr RG; Böhm-Vélez M; Mahoney MC; Evans WP; Larsen LH; Morton MJ; Mendelson EB; Farria DM; Cormack JB; Marques HS; Adams A; Yeh NM; Gabrielli G;
JAMA; 2012 Apr; 307(13):1394-404. PubMed ID: 22474203
[TBL] [Abstract][Full Text] [Related]
5. Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer.
Sung JS; Lebron L; Keating D; D'Alessio D; Comstock CE; Lee CH; Pike MC; Ayhan M; Moskowitz CS; Morris EA; Jochelson MS
Radiology; 2019 Oct; 293(1):81-88. PubMed ID: 31453765
[TBL] [Abstract][Full Text] [Related]
6. Contrast-Enhanced Digital Mammography Screening for Intermediate-Risk Women With a History of Lobular Neoplasia.
Hogan MP; Amir T; Sevilimedu V; Sung J; Morris EA; Jochelson MS
AJR Am J Roentgenol; 2021 Jun; 216(6):1486-1491. PubMed ID: 33787291
[No Abstract] [Full Text] [Related]
7. Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.
Cho N; Han W; Han BK; Bae MS; Ko ES; Nam SJ; Chae EY; Lee JW; Kim SH; Kang BJ; Song BJ; Kim EK; Moon HJ; Kim SI; Kim SM; Kang E; Choi Y; Kim HH; Moon WK
JAMA Oncol; 2017 Nov; 3(11):1495-1502. PubMed ID: 28655029
[TBL] [Abstract][Full Text] [Related]
8. Assessing tumor extent on contrast-enhanced spectral mammography versus full-field digital mammography and ultrasound.
Patel BK; Garza SA; Eversman S; Lopez-Alvarez Y; Kosiorek H; Pockaj BA
Clin Imaging; 2017; 46():78-84. PubMed ID: 28750354
[TBL] [Abstract][Full Text] [Related]
9. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Riedl CC; Luft N; Bernhart C; Weber M; Bernathova M; Tea MK; Rudas M; Singer CF; Helbich TH
J Clin Oncol; 2015 Apr; 33(10):1128-35. PubMed ID: 25713430
[TBL] [Abstract][Full Text] [Related]
10. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
11. Value Added of Preoperative Contrast-Enhanced Digital Mammography in Patients With Invasive Lobular Carcinoma of the Breast.
Patel BK; Davis J; Ferraro C; Kosiorek H; Hasselbach K; Ocal T; Pockaj B
Clin Breast Cancer; 2018 Dec; 18(6):e1339-e1345. PubMed ID: 30122347
[TBL] [Abstract][Full Text] [Related]
12. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
[TBL] [Abstract][Full Text] [Related]
13. The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.
Obdeijn IM; Mann RM; Loo CCE; Lobbes M; Voormolen EMC; van Deurzen CHM; de Bock G; ; Hooning MJ
Breast Cancer Res Treat; 2020 Jun; 181(3):581-588. PubMed ID: 32333294
[TBL] [Abstract][Full Text] [Related]
14. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the diagnostic performance of digital breast tomosynthesis and magnetic resonance imaging added to digital mammography in women with known breast cancers.
Kim WH; Chang JM; Moon HG; Yi A; Koo HR; Gweon HM; Moon WK
Eur Radiol; 2016 Jun; 26(6):1556-64. PubMed ID: 26376882
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
[TBL] [Abstract][Full Text] [Related]
17. Which clinical, radiological, histological, and molecular parameters are associated with the absence of enhancement of known breast cancers with Contrast Enhanced Digital Mammography (CEDM)?
Bicchierai G; Amato F; Vanzi B; De Benedetto D; Boeri C; Vanzi E; Di Naro F; Bianchi S; Cirone D; Cozzi D; Miele V; Nori J
Breast; 2020 Dec; 54():15-24. PubMed ID: 32889303
[TBL] [Abstract][Full Text] [Related]
18. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
19. Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI.
Yuen S; Monzawa S; Gose A; Yanai S; Yata Y; Matsumoto H; Ichinose Y; Tashiro T; Yamagami K
Breast Cancer; 2022 Jul; 29(4):677-687. PubMed ID: 35220511
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
